- Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investment Eli Lilly
- Lilly will let small biotechs use its AI models at no cost statnews.com
- Lilly invites biotechs to use AI platform to develop their drugs Fierce Biotech
- In first-of-its-kind setup, Lilly offers startups free access to its AI models in exchange for data Endpoints News
- Lilly launches AI-powered platform to accelerate drug discovery Reuters
Source link
